Key Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using ...
The 59.4% real-world pain responder rate from the use of inFoods® IBS closely mirrors the 59.6% result from the controlled trial-offering an unusual degree of consistency between controlled and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results